BIOLYTICLIFESCIENCES
ISO 13485:2016
Telangana, India

Our Journey

Building Innovation in Immunodiagnostics

Biolytic Lifesciences manufacturing facility exterior

Building Innovation in Immunodiagnostics

Since its inception, Biolytic Lifesciences Pvt. Ltd. has been committed to advancing diagnostic healthcare through innovation, quality, and scientific excellence. Our journey reflects a continuous pursuit of research-driven solutions, manufacturing excellence, and the development of reliable in-vitro diagnostic products that serve healthcare professionals and patients across diverse markets.

Our Growth Story

2021

Establishment

Biolytic Lifesciences Pvt. Ltd. was established in Telangana, India, with a vision to contribute to the field of immunodiagnostics through research, development, and manufacturing of high-quality diagnostic solutions. From the beginning, the company focused on building a strong scientific foundation and creating innovative products that address real healthcare needs.

2021-2022

Foundation & Infrastructure Development

During this phase, the company invested in developing its manufacturing infrastructure, research facilities, quality systems, and operational processes. The foundation was built in alignment with international quality standards to ensure consistency, reliability, and regulatory compliance in every stage of product development and manufacturing.

  • Establishment of manufacturing and laboratory facilities
  • Implementation of quality management systems
  • Development of research and product development capabilities
  • Creation of operational processes aligned with industry standards
2022-2023

Product Development & Manufacturing Growth

With the infrastructure and quality systems in place, Biolytic Lifesciences focused on developing and manufacturing in-vitro diagnostic products. The company successfully introduced ELISA-based diagnostic kits designed to support accurate and reliable disease detection.

  • Development of ELISA diagnostic technologies
  • Introduction of HIV ELISA Kits
  • Introduction of HCV ELISA Kits
  • Introduction of HBsAg ELISA Kits
  • Strengthening manufacturing and quality control processes
2023-Present

Expansion & Innovation

Biolytic Lifesciences continues to expand its product portfolio and research capabilities. The company has extended its focus to rapid diagnostic solutions while maintaining its commitment to affordability, accuracy, and reliability. Ongoing innovation efforts are directed toward addressing emerging healthcare challenges and supporting improved diagnostic outcomes.

  • Expansion into Rapid Diagnostic Kits
  • Development of Syphilis Rapid Test Solutions
  • Research initiatives in advanced immunodiagnostic technologies
  • Continuous improvement of manufacturing and quality systems
  • Focus on delivering accessible and dependable healthcare solutions

Looking Ahead

As Biolytic Lifesciences moves forward, the company remains dedicated to innovation, scientific excellence, and quality-driven manufacturing. Through continuous research and product development, we aim to contribute to better healthcare outcomes and make advanced diagnostic solutions more accessible to healthcare providers worldwide.